Leelamine
Leelamine is an orally active pyruvate dehydrogenase kinase (PDK) inhibitor with an IC50 value of 9.5 μM, showing a blood glucose lowering effect in the diabetic mouse. Leelamine is also a weak agonist of cannabinoid receptors CB1 and CB2. Leelamine decreases mitotic activity, prostate-specific antigen expression and induces Apoptosis to cell death in cancer cells[1][2][3].
Product Specifications
CAS Number
1446-61-3
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Cannabinoid Receptor; PDK-1
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/leelamine.html
Concentration
10mM
Purity
98.36
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
NC[C@]1(C)CCC[C@]2(C)C3=C(CC[C@@]12[H])C=C(C(C)C)C=C3
Molecular Formula
C20H31N
Molecular Weight
285.48
Precautions
H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CB1; CB2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cyp2j7 Mouse shRNA Lentiviral Particle (Locus ID 546837)
Human Hereditary hemochromatosis protein (HFE) ELISA kit